Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Horowitz, MD
Center for International Blood and Marrow Transplant Research
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- City of Hope National Medical Center
Duarte, California, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Bmt Northside
Atlanta, Georgia, United States
- Emory University
Atlanta, Georgia, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- University of Kentucky
Lexington, Kentucky, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Ohio State/arthur G. James Cancer Hospital
Columbus, Ohio, United States
- University of Texas /md Anderson Crc
Houston, Texas, United States
- West Virginia University
Morgantown, West Virginia, United States
- University of Wisconsin Hospital & Clinics
Madison, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2015
- Primary completion
- 1 Oct 2020
- Completion
- 1 Oct 2020
- Last update posted
- 4 Jan 2023
- Registered enrollment
- 57
- Registry id
- NCT02440464
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.